Abdullah Noor Rafhati Adyani, Jason Wong Lok Chin, Nasruddin Azraai Bahari
Endocrinology Unit, Department of Medicine, Putrajaya Hospital, PutrajayaMalaysia.
Department of Medicine, National University of Malaysia Medical Centre, Kuala LumpurMalaysia.
Endocrinol Diabetes Metab Case Rep. 2017 May 16;2017. doi: 10.1530/EDM-17-0029. eCollection 2017.
Pachydermoperiostosis is a very rare osteoarthrodermopathic disorder whose clinical and radiographic presentations may mimic those of acromegaly. In the evaluation of patients with acromegaloid appearances, pachydermoperiostosis should be considered as a differential diagnosis. In this article, we report a 17-year-old boy who presented with 2-year history of acral enlargement and facial appearance changes associated with joint pain and excessive sweating. He had been investigated extensively for acromegaly, and the final diagnosis was pachydermoperiostosis.
There is a broad range of differential diagnosis for acromegaloid features such as acromegaly, pseudoacromegaly with severe insulin resistance, Marfan's syndrome, McCune-Albright and a rare condition called pachydermoperiostosis.Once a patient is suspected to have acromegaly, the first step is biochemical testing to confirm the clinical diagnosis, followed by radiologic testing to determine the cause of the excess growth hormone (GH) secretion. The cause is a somatotroph adenoma of the pituitary in over 95 percent of cases.The first step is measurement of a serum insulin-like growth factor 1 (IGF1). A normal serum IGF1 concentration is strong evidence that the patient does not have acromegaly.If the serum IGF1 concentration is high (or equivocal), serum GH should be measured after oral glucose administration. Inadequate suppression of GH after a glucose load confirms the diagnosis of acromegaly.Once the presence of excess GH secretion is confirmed, the next step is pituitary magnetic resonance imaging (MRI).Atypical presentation warrants revision of the diagnosis. This patient presented with clubbing with no gigantism, which is expected in adolescent acromegalics as the growth spurt and epiphyseal plate closure have not taken place yet.
厚皮性骨膜病是一种非常罕见的骨关节皮肤疾病,其临床和影像学表现可能与肢端肥大症相似。在评估有肢端肥大症样外观的患者时,应将厚皮性骨膜病视为鉴别诊断之一。在本文中,我们报告了一名17岁男孩,他有2年的肢端增大和面部外观改变病史,伴有关节疼痛和多汗。他曾被广泛检查是否患有肢端肥大症,最终诊断为厚皮性骨膜病。
对于肢端肥大症样特征有广泛的鉴别诊断,如肢端肥大症、伴有严重胰岛素抵抗的假性肢端肥大症、马凡综合征、McCune - Albright综合征以及一种罕见的疾病厚皮性骨膜病。一旦怀疑患者患有肢端肥大症,第一步是进行生化检测以确诊临床诊断,随后进行影像学检测以确定生长激素(GH)分泌过多的原因。在超过95%的病例中,病因是垂体生长激素腺瘤。第一步是测量血清胰岛素样生长因子1(IGF1)。血清IGF1浓度正常是患者没有肢端肥大症的有力证据。如果血清IGF1浓度高(或不明确),应在口服葡萄糖后测量血清GH。葡萄糖负荷后GH抑制不足可确诊肢端肥大症。一旦确认存在GH分泌过多,下一步是进行垂体磁共振成像(MRI)。非典型表现需要重新审视诊断。该患者表现为杵状指但无巨人症,这在青春期肢端肥大症患者中是可以预期的,因为生长突增和骨骺板闭合尚未发生。